Current Edition

Current Perspective on TBI

Dr Adrian Harel of Medicortex conveys the urgency of developing mitigating therapeutics for the secondary and long-term damaging effects of TBI. His article makes clear that in order to ensure effectiveness, new treatment options must be multifaceted and include neuroprotective, neurorestorative and anti-inflammatory agents. Soon the day may come when brain injuries of children, seniors, athletes, service personnel, and others, will be treated in much the same way injuries in other parts of the body are currently being treated.
http://ipimediaworld.com/wp-content/uploads/2014/07/Current-Perspective.pdf